Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0C4PD
|
|||
| Drug Name |
PMID25726713-Compound-38
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H30F3N7O3
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)CN2CCOCC2)NC(=O)C3=CC=C(C=C3)NC4=NC(=C5C(=N4)N(C=N5)C)C6=CC=C(C=C6)OC(F)(F)F
|
|||
| InChI |
1S/C32H30F3N7O3/c1-20-3-4-21(18-42-13-15-44-16-14-42)17-26(20)38-30(43)23-5-9-24(10-6-23)37-31-39-27(28-29(40-31)41(2)19-36-28)22-7-11-25(12-8-22)45-32(33,34)35/h3-12,17,19H,13-16,18H2,1-2H3,(H,38,43)(H,37,39,40)
|
|||
| InChIKey |
RXPJNNAJKCJKEX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Smoothened homolog (SMO) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Smoothened homolog (SMO) | Target's Patent Info | [1] | |
| KEGG Pathway | Hedgehog signaling pathway | |||
| Pathways in cancer | ||||
| Proteoglycans in cancer | ||||
| Basal cell carcinoma | ||||
| Panther Pathway | Hedgehog signaling pathway | |||
| Pathway Interaction Database | Signaling events mediated by the Hedgehog family | |||
| Hedgehog signaling events mediated by Gli proteins | ||||
| Reactome | Class B/2 (Secretin family receptors) | |||
| Hedgehog 'off' state | ||||
| Activation of SMO | ||||
| WikiPathways | Hedgehog Signaling Pathway | |||
| Hair Follicle Development: Organogenesis (Part 2 of 3) | ||||
| Hair Follicle Development: Induction (Part 1 of 3) | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| GPCR ligand binding | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Hedgehog inhibitors: a patent review (2013 - present).Expert Opin Ther Pat. 2015 May;25(5):549-65. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.